Paragon Care Ownership

PXS Stock  EUR 0.28  0.01  3.70%   
Paragon Care owns a total of 657.85 Million outstanding shares. Paragon Care has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Paragon Care Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Paragon Stock Ownership Analysis

About 42.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.85. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Paragon Care Limited last dividend was issued on the 14th of March 2023. The entity had 1:10 split on the 19th of July 2011. Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia and New Zealand. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. PARAGON CARE operates under Medical Distribution classification in Germany and is traded on Frankfurt Stock Exchange. It employs 508 people. To find out more about Paragon Care Limited contact BBus CPA at 61 3 8833 7800 or learn more at https://www.paragoncare.com.au.

Paragon Care Outstanding Bonds

Paragon Care issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Paragon Care Limited uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Paragon bonds can be classified according to their maturity, which is the date when Paragon Care Limited has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Currently Active Assets on Macroaxis

Other Information on Investing in Paragon Stock

Paragon Care financial ratios help investors to determine whether Paragon Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Paragon with respect to the benefits of owning Paragon Care security.